A detailed history of Pathstone Holdings, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 242,363 shares of ABBV stock, worth $40 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
242,363
Previous 244,957 1.06%
Holding current value
$40 Million
Previous $42 Million 13.91%
% of portfolio
0.22%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $425,000 - $517,062
-2,594 Reduced 1.06%
242,363 $47.9 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $162,374 - $189,617
-1,049 Reduced 0.43%
244,957 $42 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $557,292 - $634,982
-3,487 Reduced 1.4%
246,006 $44.8 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $34.3 Million - $38.7 Million
249,493 New
249,493 $38.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.